Anthera Pharmaceuticals Inc (NASDAQ:ANTH)

CAPS Rating: 2 out of 5

Recs

1
Player Avatar zzlangerhans (99.78) Submitted: 7/19/2012 1:49:34 AM : Underperform Start Price: $1.74 ANTH Score: +37.25

When is a failed study not a failed study? When the company says the results were misunderstood, and Seeking Alpha pumpers appear to echo the sentiment, and day traders grab the football and run with it. What should management do when handed this gift? Dilute? You betcha!

Featured Broker Partners


Advertisement